S.T. Stent is developing a removable stent for use after Functional Endoscopic Sinus Surgery (FESS) to keep the sinus cavity open for almost a month, long enough for the tissue to heal.
The stent, for insertion after FESS, keeps the sinus cavity open up to 28 days, long enough for the sinus tissue to heal. The stent improves patient outcomes and reduces the probability of revision surgeries.
Stage: Business development
Founded: November 2013
Investors: The Trendlines Group, private investor
IP: Three issued patents, two pending
Achievements: December 2016: Successful first-in-human pilot (removable sinus stents were inserted into 6 patients and removed after a few weeks with excellent results)
Chronic sinusitis is constant inflammation of the sinus caused by infection or allergy and characterized by facial pain and pressure, nasal congestion, and headaches. When drug treatments fail, Functional Endoscopic Sinus Surgery (FESS) is performed to improve airflow within the nose and sinuses, improve drainage, and eliminate diseased tissue.
Unfortunately, up to 30% of sinus surgeries fail due to scarring and recurrent inflammation that closes the nasal openings and requires revision sinus surgery
There are more than 1 million FESS procedures performed annually in the United States and Europe.
Portable, automatic system for peritoneal dialysis
Device for treating ischemic stroke
Anastomotic closure device for laparoscopic bowel resection
Miniature screwless spine fusion implant
Noninvasive monitoring for the diagnosis of heart failure